Regular Coffee Consumption Might Reduce Risk of Cancer Progression in Metastatic Colorectal Cancer Patients, Study Suggests

Jan, 2021 - By SMI

According to a new study initiated by the researchers of Dana-Farber Cancer Institute involving large pool of patients with metastatic colorectal cancer, reported that intake of a few cups of coffee in a day drops the risk of the cancer progression and aids in longer survival. Moreover, the findings was based on the data from a large observational study.

In this study, researchers observed that 1,171 patients who underwent treatment for metastatic colorectal cancer and reported of consuming two to three cups of coffee a day had longer survival rate and the cancer progression also declined, in comparison to patients without coffee. Furthermore, researchers also found that patients with larger amounts of coffee, consuming over four cups a day experienced more positive outcomes.  The benefits included both caffeinated and decaffeinated coffee. However, this outcomes allowed researchers to create an association, the study doesn't provide any confirmation.

Dana-Farber's Chen Yuan, ScD, the co-first author of the study stated, “It's known that several compounds in coffee have antioxidant, anti-inflammatory, and other properties that may be active against cancer. Epidemiological studies have found that higher coffee intake was associated with improved survival in patients with stage 3 colon cancer, but the relationship between coffee consumption and survival in patients with metastatic forms of the disease hasn't been known.”

Researchers also informed that the study is in its primitive stage and further studies are required, hence it cannot conclude that high intake of coffee could be a potential treatment for colorectal cancer, however coffee consumption might not be harmful but beneficial up to a certain extent.